Research describes how two different methods of inhibiting both VEGF and angiopoietin-2 in animal models normalized Gliobastoma tumor blood vessels to a greater extent than anti-VEGF therapy alone, it also shifted the action of tumor-infiltrating immune cells from a pro-tumor to an anti-tumor state.

See the source article by following the link below:
Research describes how two different methods of inhibiting both VEGF and angiopoietin-2 in animal models normalized Gliobastoma tumor blood vessels to a greater extent than anti-VEGF therapy alone, it also shifted the action of tumor-infiltrating immune cells from a pro-tumor to an anti-tumor state.